Mass religious gatherings events and COVID-19 –easing of COVID-19 restrictions and a staged approach to scaling up the Umrah Pilgrimage

• Autor: Al-Tawfiq, J.A. ; Memish, Z.A. ; Zumla, A.
• Assuntos: Capacity development ; Communicable Disease Control ; Coronaviruses ; COVID-19 ; COVID-19 - prevention & control ; COVID-19 - transmission ; COVID-19 vaccines ; Developing countries ; Disease transmission ; Humans ; Infections ; Infectious diseases ; Islam ; LDCs ; Mass gatherings religious events, Hajj ; Middle East respiratory syndrome ; Mutation ; Pandemics ; Pilgrimages ; Proteins ; Public Health ; Respiratory diseases ; SARS-CoV-2 - isolation & purification ; SARS-CoV-2, COVID-19, restrictions, scaleup ; Saudi Arabia - epidemiology ; Scaling ; Severe acute respiratory syndrome coronavirus 2 ; Social distancing ; Surveillance ; Travel ; Travel medicine ; Umrah
• É parte de: Travel medicine and infectious disease, 2021-03, Vol.40, p.101986-101986, Article 101986
• Notas: SourceType-Other Sources-1
  content type line 63
  ObjectType-Editorial-2
  ObjectType-Commentary-1
  
• Descrição: The 2020 Hajj was a resounding public health success and ended on Monday August 3, 2020 with no COVID-19 cases detected [9]. Since the first reported case of COVID-19 in March 2020 in Saudi Arabia, there have been a total 365,325 COVID-19 cases with 6335 deaths (CFR: 1.7%) as of January 19, 2021. On October 4th, 2020, the KSA Interior Ministry announced a series of staged measures for the gradual resumption of the Umrah. Since the Umrah rituals can be completed within few hours an upward scale of the activity [9] has been suggested (Fig. 1). Sir Prof Alimuddin Zumla is a co-PI of the Pan-African-European Network for Pandemic Preparedness, Research and capacity development for Emerging and Re-Emerging Infections (PANDORA-ID-NET; https://www.pandora-id.net/) and Member of the CANTAM and EACCR networks of excellence, funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) the EU Horizon 2020 Framework Programme for Research and Innovation.
  
• Editor: Netherlands: Elsevier Ltd
  
• Idioma: Inglês